IDBS and Alchemi Agree to Accelerate AI-Driven Biopharma Regulatory Filings
IDBS, which provides cloud software for biopharma, and Alchemi, an applied AI company, partnered to connect AI agents to data captured and contextualized in the IDBS Polar platform across the drug development lifecycle. By capturing such data at the point of creation within a single governed backbone, Polar delivers the data foundation that makes agentic AI viable in regulated environments, explains IDBS in a statement.
巴斯夫在埃及推出嗪虫唑酰胺杀虫剂，为高价值作物引入新型作用机制
世界农化网中文网报道：近日，巴斯夫农业解决方案部门在埃及推出新款杀虫剂Efficon®，含新型活性成分Axalion® Active（嗪虫唑酰胺），针对蔬菜和马铃薯等经济作物的刺吸式口器害虫提供防控方案。
The Protein Brewery wins EU approval for Fermotein mycoprotein six years after novel foods filing
The first novel mycelium ingredient authorized for sale in the EU under the Novel Food Regulation should hit the market …
Business Finland Commits EUR 77.8M to Solar Foods’ Industrial Solein Facility
Finnish food technology company Solar Foods has secured EUR 77.8 million in combined public financing for the construction and commissioning of Factory 02, its planned industrial-scale Solein production facility in Selkäharju, Lappeenranta.
Unlocking Productivity In High P-FIXING Soils
June 2026, AU: Fertiliser is one of the most significant input costs facing growers, so knowing where to apply it to max…
科迪华三氟咪啶酰胺杀线剂在巴西推出：三大品牌分攻大豆、甘蔗与经济作物
世界农化网中文网报道：科迪华近日在2026年巴西巴伊亚农场展上正式推出新型杀线虫剂Reklemel™（活性成分，三氟咪啶酰胺）。与市面上多数传统杀线虫剂不同，Reklemel并非″广谱防治″，而是选择性靶向植物寄生线虫，同时保留土壤中的自由生活线虫、有益细菌和真菌等群体，从而维护土壤的生物平衡与健康。
China Sets Framework for Advanced Therapeutic Development
China’s Order 818—Regulations on the Administration of Clinical Research and Clinical Translation and Application of Biomedical New Technologies—establishes a new commercialization pathway for cell and gene therapeutics, gene editing, and other advanced therapeutics. More importantly, it signals China’s intent to accelerate local innovation and standardize the drug development environment, thereby becoming a more important player in advanced therapy development and manufacturing.
World Food Safety Day / Africa Regional Webinar Emphasizes Turning Foodborne Disease Burden Evidence Into Sustainable Action
June 2026, US: Transforming evidence into action is essential to reducing the burden of foodborne diseases and building …
Investment Climate Podcast: Jaap Zijlstra of Navus on Why “Process Tech” is the Missing Link in Scaling AgriFood
In this podcast series, Alex Shandrovsky interviews investors about benchmarks for funding Alt Proteins in 2026 and uncovers the investment playbooks of successful Climate Tech CEOs and Leading VCs.
Perseverance, Persistence Key to CAR T Success, Say Ross Prize Winners Carl June and Michel Sadelain
NEW YORK CITY — Patients, colleagues and peers gathered in midtown Manhattan last week to celebrate Carl June, MD, and Michel Sadelain, MD, PhD, who shared the 13th annual Ross Prize in Molecular Medicine.